12 alternative Treatments

Here is detailed information about Twelve Alternative Cancer Treatments that are supported by scientific evidence and patient testimonials.

Treatments:
High Intensity Focussed Ultrasound
Cannabinoids
Gonzalez Protocol
Iscador (Mistletoe)
Antineoplastons
Gerson Therapy
Oncolytic Virotherapy
Insulin Potentiated Therapy
Intravenous Vitamin C
Laetrile
Issels Immunotherapy
Budwig Diet

High-intensity focused ultrasound (HIFU)

 

What the Irish Cancer Society tells us:

This is the only reference to HIFU on the Irish Cancer Society website (where it is grouped with Cryotherapy):

Irish Cancer Society website:
“Both of these treatments are currently being researched to see if they are as effective at treating certain kinds of prostate cancer as other standard type treatments like surgery and radiotherapy. At present neither of these treatments are available in Ireland but are available in some centres in Europe often under a clinical trial.”

What the Society doesn’t tell us:

HIFU technology treats prostate cancer by focusing high-intensity ultrasound waves on the affected area, causing localized heating that destroys the cells in the gland without damaging the surrounding tissue.

Focused ultrasound works in the same way as rays of sunlight that pass through a magnifying glass and are concentrated at a single point, causing a significant temperature rise around the focal point.
Thermal ablation is a non-invasive (incisionless and radiation-free) treatment that has been used in humans since 1993.
Source: Focused Ultrasound Foundation

In clinics, HIFU has been applied to treat a variety of solid malignant tumors including:
• pancreas,
• liver,
• prostate,
• breast,
• uterine fibroids, and
• soft-tissue sarcomas.

In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the advantages of non-invasion, non-ionization, and fewer complications after treatment. Over 100,000 cases have been treated throughout the world with great success.
Source: World Journal of Clinical Oncology

 

Proof that it works
It is being used successfully to treat cancer.

The HIFU treatment is recognized by the orders of urology specialists in several countries.
Source: hifuplanet

With more than 40,000 treatments performed using HIFU medical device, it is no longer considered as an experimental procedure and its effectiveness has been demonstrated.

Focused ultrasound treatments can be performed on an outpatient basis, require no incisions, and can result in minimal discomfort and few complications, allowing for rapid recovery.
Source: Focused Ultrasound Foundation

High intensity focused ultrasound in clinical tumor ablation
In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well-defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft-tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the advantages of non-invasion, non-ionization, and fewer complications after treatment. Over 100,000 cases have been treated throughout the world with great success.

Source: World Journal of Clinical Oncology

Metastatic Bone Cancer
Physicians at the University Medical Center – Utrecht, the Royal Marsden Hospital in Sutton, U.K., and elsewhere are effectively treating painful bone metastases with the MR-guided high intensity focused ultrasound system (MR-HIFU) called Philips Sonalleve MR-HIFU. Palliative bone metastases pain therapy with MR-HIFU can lead to fast pain relief, has fewer side effects than traditional treatments, and helps patients quickly return to normal activities.

Source of this information: Philips

In the later stages of their disease, many cancer patients develop bone metastases, which can cause severe and debilitating pain. UMC Utrecht is using innovative Sonalleve MR-HIFU therapy to treat non-invasive palliative pain treatment of bone metastases.
Dr. Merel Huisman, radiologist. Professor Maurice van den Bosch, Chairman Department of Radiology & Nuclear Medicine

“We started to treat our cancer patients for their pain from bone metastasis with the Sonalleve MR-HIFU system. The results had been exciting from the beginning; most of our patients experience a very significant pain relief within a week of having the procedure”.
Professor Nandita deSouza, co-director of The Institute of Cancer Research, Sutton, Surrey, UK.

Proof that it works
Published Clinical Trials / Studies / Reviews:

This study says:
In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well-defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft-tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the advantages of non-invasion, non-ionization, and fewer complications after treatment. Over 100,000 cases have been treated throughout the world with great success.

This study says:
Pain relief was achieved in 79.5% of patients…preliminary results demonstrate the safety of clinical application of HIFU for pancreatic cancer and reveal it to be a promising mode of treatment for local advanced pancreatic cancers.

This study says:
It can effectively alleviate cancer-related abdominal pain, and may confer an additional survival benefit with few significant complications.

This study says:
A variety of solid tumors have been tried on thousands of patients in the last fifteen years with great success.

This study says:
This study demonstrates the effective long-term cancer control achieved with HIFU in patients with low or intermediate-risk localised prostate cancer.

This study says:
HIFU for localized prostate cancer offered high control of local disease with low morbidity.

This study says:
Salvage HIFU is a curative treatment option for local relapse after EBRT [external beam radiation] with acceptable morbidity.

This study says:
Image-guided FUS is both safe and effective in the treatment of primary and secondary tumours.

This study (patients with painful bone metastasis) says:
All patients showed significant pain relief within 2 weeks. Two patients experienced complete pain reduction that lasted for 1 year.

This study concludes:
In this, the largest prospective series to date, we demonstrate that salvage HIFU for locally recurrent prostate cancer after failed primary brachytherapy has encouraging disease control results, albeit with a relatively high complication rate.

This study concludes:
We suggest that HIFU therapy is safe and has the potential to be a new method of combination therapy for PC.

This 2017 study concluded:
We believe that the proposed combinational blue light emitting diode-high frequency focused ultrasound treatment could have therapeutic benefits to alleviate cancer cell proliferation.

This 2016 study says:
The reviewed FUS [Focused Ultrasound] – induced immunomodulation effects can be harnessed to current and developing immunotherapy approaches. Together, these may overcome GBM [ glioblastoma multiforme] – induced immune-evasion and generate a clinically relevant anti-tumor immune response.

This study says:
The findings suggest that this novel technology can be used to induce SMMC-7721 apoptosis via the Ca(2+)/mitochondrial pathway and could potentially be of clinical use for the treatment of hepatocellular carcinoma (SMMC-7721 cell line) and other cancers.

(more available on PubMed)

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Proof that it works
Patient testimonials

Mayor Parkin

Meet David

“It is 12 years since I was treated and have moved from a 58 year old to a 70 year old. For the last 6 years I have been mayor of my local city and I attach a photograph in regalia with my five grandchildren, all born since my treatment. You may use this also if you like to reassure potential patients that there is normal and interesting life after HIFU.”
-David Parkin

See more patient testimonials

Even more patient testimonials

Back to top

Cannabinoids

 

“It is legal to kill a man to save your own life.
It is illegal to use a plant to do the same.”

What the Irish Cancer Society tells us:

There is no mention of Cannabinoids on the Irish Cancer Society website.

What the Society doesn’t tell us:

Cannabinoids are active chemicals in Cannabis that cause drug-like effects throughout the body, including the central nervous system and the immune system. They are also known as phytocannabinoids. The main active cannabinoid in Cannabis is delta-9-THC. Another active cannabinoid is cannabidiol, which may relieve pain and lower inflammation without causing the “high” of delta-9-THC.

Cannabinoids may be useful in treating the side effects of cancer and cancer treatment.

Other possible effects of cannabinoids include:
Blocking cell growth.
Preventing the growth of blood vessels that supply tumors.
Source: The website of the National Cancer Institute (http://www.cancer.gov)

Proof that it works
It is being used successfully to treat cancer.

Medical Cannabis is legally available through physicians in a number of countries around the world, including Croatia, the US and Canada. It is not yet available in Ireland, although the government talked about introducing legislation.

Proof that it works
Published Clinical Trials / Studies / Reviews:

Brain Cancer
A study published in the British Journal of Cancer, conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth… THC was found to decrease tumour cells in two out of the nine patients.

A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess antitumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour. The study concluded that cannabidiol was able to produce a significant antitumor activity.

Breast Cancer
A study published in the US National Library of Medicine, conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.

A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.

A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.

Lung Cancer
A study published in the journal Oncogene, by Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more.

A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology, from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient. Overall, data indicated that cannabinoids decrease cancer cell invasiveness.

A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.

Prostate Cancer
A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.

A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.

Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.

Blood Cancer
A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma.

A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.

A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.

Oral Cancer
A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours.

Liver Cancer
A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.

Pancreatic Cancer
A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.

Here’s a list of 100 studies.
(Published on Higher Perspective)

Cannabis kills tumor cells

Uterine, testicular, and pancreatic cancers

Brain cancer

Mouth and throat cancer

Breast cancer

Lung cancer

Prostate cancer

Blood cancer

Skin cancer

Liver cancer

Cannabis cancer cures (general)

Cancers of the head and neck

Cholangiocarcinoma cancer

Leukemia

Cannabis partially/fully induced cancer cell death

Translocation-positive rhabdomyosarcoma

Lymphoma

Cannabis kills cancer cells

Melanoma

Thyroid carcinoma

Colon cancer

Intestinal inflammation and cancer

Cannabinoids in health and disease

Cannabis inhibits cancer cell invasion

“Alternative therapies are not scientifically proven.”
Irish Cancer Society


“I use cannabis a lot in my cancer population, with very positive results.”
Mark S. Wallace, MD, professor of clinical anesthesiology at the University of California, San Diego


Proof that it works
Patient testimonials

Cannabis oil cures terminal cancer in 3-year-old after pharmaceutical drugs fail miserably
Source: Natural News

(NaturalNews) A 3 year-old Utah boy, diagnosed with leukemia and told by doctors that he had mere days to live, is now alive and well not because he continued his chemotherapy, but because he obtained cannabis oil treatment instead.

The family, fed up with the fact that the only treatment doctors could recommend was chemotherapy–even after little Landon Riddle kept vomiting dozens of times daily and refused to eat after two months of chemo–looked into cannabis oil treatment. After reading up about it online and researching the details, they traveled to Colorado where such a treatment is legal, to help Landon.
Continue reading full article at Natural News
Landon Riddle

Landon last year. Source: Landon’s Facebook Page


How Cannabis Oil Helped Cure This Young Girl’s Leukemia
Source:
Spiritscience

7-year-old Mykayla Comstock was diagnosed with leukemia in the summer of 2012. Her mother, Erin Purchase, wasted no time and enrolled her daughter in the Oregon Medical Marijuana Program.

Much to everyone’s surprise, just one week after beginning the cannabis oil therapy, scans of Mykayla’s bone marrow and blood showed no signs of leukemia. She was in remission!

Mykeyla’s Facebook page

 

Cannabis Oil Cures 8 Month Old Infant of Cancer

Back to top

Gonzalez Protocol

 

What the Irish Cancer Society tells us:

There is no information about the Gonzalez Protocol on the Irish Cancer Society website.

What the Society doesn’t tell us:

The Gonzalez Protocol combines personalised diets, nutritional supplements, coffee enemas, and pancreatic enzymes in a cancer management program.

The pancreatic enzymes are thought to be the specific anticancer component of the Gonzalez program.

Results from a pilot study published in 1999 described the most positive data in the medical literature for pancreatic cancer.

Note: Nicholas J. Gonzalez, M.D. died on Tuesday, July 21, 2015. Nick’s wife, Mary Beth, has started The Nicholas Gonzalez Foundation which is committed to keeping the brilliant, healing work of Dr. Nicholas Gonzalez alive today and for generations to come.

Since 1987, Dr. Gonzalez had been in private practice in New York City, treating patients diagnosed with cancer and other serious degenerative illnesses.

His clinic and work continues under the leadership of Dr Linda Isaacs.

 

Our Treatment Program

Source: Dr-Gonzalez.com
Although our published research deals with pancreatic cancer, in our office we treat patients with all types of cancers. We also treat patients with a variety of other problems, ranging from chronic fatigue syndrome to multiple sclerosis. Each treatment protocol is individualized for each patient, regardless of the underlying problem.

The regimen can be broken down into the following basic components: diet, supplements (with pancreas product for cancer patients) and detoxification routines such as coffee enemas.

Diet: The prescribed diets are quite variable, and can range from nearly vegetarian to diets requiring red meat 2-3 times a day. Each patient receives individualized dietary recommendations. All the diets, however, require that the patient consume primarily organic foods, make and drink fresh vegetable juice, and avoid synthetic and refined foods such as white flour and white sugar. (A more detailed explanation of the rationale behind the diets can be found in the interview from Clinical Pearls News, or in an article from TotalHealth Magazine).

Supplements: Like the diets, the supplement protocols are individualized for each patient, depending on their health problems and biochemical makeup. The prescribed supplements include a variety of vitamins, minerals, trace elements, anti-oxidants, animal glandular concentrates and other food concentrates.

Pancreas Product (For Cancer Patients): The main anti-cancer supplement is a specially manufactured pancreas product (containing naturally occurring enzymes) made from pig pancreas. Cancer patients on this regimen take up to 45 grams of pancreas product a day, taken orally and spread throughout the day.

The pancreas product we use was developed by us specifically for use in this program

Overall, cancer patients will consume 130-175 capsules a day, including nutrients as well as pancreas product. Non-cancer patients might consume in the range of 80-100 capsules a day, the exact number depending on their health status and medical problems.

Detoxification: On this therapy, patients – whatever their underlying problem – routinely develop a variety of symptoms, most commonly described as “flu-like,” such as muscle aches and pains or malaise. We hypothesize these symptoms result from the body’s repair processes which release all manner of waste material. “Detoxification” refers to procedures such as the coffee enema, which are believed to enhance liver function and in turn, the processing and excretion of metabolic wastes. The coffee enemas are done twice daily, and patients most commonly report symptomatic relief… continue reading at Dr-Gonzalez.com

The Gonzalez Protocol is only available at the New York office of Dr Linda Isaacs.

Published Clinical Trials / Studies / Reviews

THE GONZALEZ THERAPY AND CANCER: A COLLECTION OF CASE REPORTS

This study says:
As of 12 January 1999, of 11 patients entered into the study, 9 (81%) survived one year, 5 (45%) survived two years, and at this time, 4 have survived three years. Two patients are alive and doing well: one at three years and the other at four years. These results are far above the 25% survival at one year and 10% survival at two years for all stages of pancreatic adenocarcinoma reported in the National Cancer Data Base from 1995.

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Testimonials

Dr-Gonzalez.com (Pancreatic Cancer)

Dr-Gonzalez.com (Other Cancer Types)Back to top

Back to top

Iscador (Mistletoe)

 

What the Irish Cancer Society tells us:

Irish Cancer Society website:
Iscador (mistletoe) Known benefits: There is no evidence that mistletoe cures cancer. Some studies report increased survival times but more research is needed.

What the Society doesn’t tell us:

Mistletoe is a semiparasitic plant that grows on several types of common trees such as apple, oak, pine, and elm. Mistletoe extract has been used since ancient times to treat many ailments.

Mistletoe is one of the most widely studied complementary and alternative medicine therapies in people with cancer. In certain European countries, preparations made from European mistletoe are among the most prescribed drugs for patients with cancer.
Mistletoe extracts are usually given by injection under the skin or, less often, into a vein, into the pleural cavity, or into the tumor.
Source: The website of the National Cancer Institute (http://www.cancer.gov)

 

Proof that it works
It is being used successfully to treat cancer.

In certain European countries, preparations made from European mistletoe are among the most prescribed drugs for patients with cancer.
Source: National Cancer Institute

Mistletoe therapy for malignancies is widespread in Europe, particularly in Switzerland and Germany. Copious pre-clinical results describing the effectiveness of mistletoe therapy are available. There is some evidence for clinical effectiveness deriving from prospective randomized studies that show a positive influence on the quality of life Increase in survival seems likely as suggested by retrospective studies conducted in recent years.
Source: International Symposium – New Directions in Cancer Management

Proof that it works
Published Clinical Trials / Studies / Reviews:


This study
concluded:
Iscador treatment can achieve a clinically relevant prolongation of survival time of cancer patients and appears to stimulate self-regulation.

This study concluded:
Pooled analysis of clinical studies suggests that adjuvant treatment of cancer patients with the mistletoe extract Iscador is associated with a better survival.

This study says:
…it could be shown that Iscador offers benefits–symptom control, overall survival…

This study says:
The analyzed studies give some evidence that Iscador treatment might have beneficial short-time effects on QoL-associated dimensions and psychosomatic self-regulation.

This study concluded:
ISCADOR Q, showing multiple positive effects in the treatment of glioblastoma, may be a candidate for concomitant treatment of this cancer.

This study says:
Intravenous mistletoe therapy was found to be safe and prospective studies for efficacy are recommended.

This study says:
This is the first report showing complete regression of a colon adenoma after intratumoural injection with Viscum album extract.

This study says:
In Germany, Switzerland and Austria, extracts derived from mistletoe (Viscum album L.) such as Iscador, Abnobaviscum, Helixor, Iscar, Iscucin and Isorel have been used in oncology for many years. These extracts have immunomodulating and immunostimulating properties, as demonstrated by experimental studies as well as in clinical trials.

This study says:
Mistletoes have emerged as promising alternative therapy against colon, oral, lung, and pancreas cancers. The plant extracts bolster immunity, delay tumour initiation and progression, kill malignant tumours, stabilize DNA, alleviate side effects of chemotherapeutics, improve the lifespan, and coping ability of cancer patients and survivors.

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Proof that it works
Patient testimonials

Suzanne Somers
American actress, author, TV show host etc (diagnosed with breast cancer in 2001)

“Over the 10 years I injected it daily, I never had a cold or flu or even a day where I didn’t feel up to par,”

 

 

 

 

Xavier GranierJavier

A cancer patient says he’s in remission thanks to regular mistletoe jabs. Xavier Granier, 79, given just weeks to live 10 years ago.
Full story at mirror.co.uk

“Miracle mistletoe’ saved my life” Xavier Granier

A study reported in 2013 that Xavier had made a full recovery and “was deemed cancer-free both clinically and radiologically.”
Back to top

Antineoplastons

 

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website

What the Society doesn’t tell us:

Antineoplastons were discovered by Stanislaw R. Burzynski, M.D., Ph.D. in 1967 who first identified their anti-cancer properties. Antineoplastons are naturally occurring peptides demonstrating ability to re-program cancer cells without destroying normal cells.

Despite a track record dwarfing that of conventional cancer treatments, including outright curing some forms that, until now, were previously thought of as “incurable,” the government and the medical establishment has been fighting tooth-and-nail to prevent public knowledge of this technology…(The Telegraph)

 

Proof that it works
It is being used successfully to treat cancer.

Treating Cancer Since 1977
Established in 1977, the Burzynski Clinic has grown to be a nationally and internationally recognized cancer center that provides cutting-edge cancer treatments.

For over 35 years, Dr. Burzynski’s cancer research and patient care has been inspired by the philosophy of the physician Hippocrates: ‘First, do no harm’. Therefore, our approach to treatment is ‘personalized’ in an atttempt to maximize effectiveness and minimize side effects for each cancer patient.

Personalized medicine may include the combination of targeted therapies with conventional therapy. It may also involve the use of investigational agents (Antineoplastons), as approved by the FDA. Patients and/or their caretakers receive training for administering all therapies at home, as well as nutritional counseling.
Source: Burzynski Clinic

Dr Burzynski’s patients
My name is Teresa Kennett. I was diagnosed with stage 4 cancer and given less than a year to live by my oncologist who also told me that conventional treatment could not cure me but could only temporarily slow the progression of my form of Non-Hodgkin’s Lymphoma.

I was a young mother with a three-month old baby girl. Desperately I sought other solutions and found Dr. Stanislaw Burzynski, whose non-toxic Antineoplaston treatment put my cancer into complete remission and saved my life.

That was over 27 years ago!

And I am not alone! Over 1000 cancer patients like Faye Joseph, MaryJo Siegel and myself (left to right above–Rita Starr, mother in remission over 20 years, Faye Joseph, in remission 4 years, Steve Siegel, Teresa Kennett, remission 27 years, Mary Jo Siegel remission 21 years) who previously received terminal diagnoses are alive today because they were treated by Dr. Burzynski.

Burzynski Patients

Pic from a petition on change.org

Proof that it works
Published Clinical Trials / Studies / Reviews:

This study says:
The results of this study compare favorably to the other trials in patients with RPDIPG [recurrent pediatric diffuse intrinsic pontine gliomas]. The survival data in most of these trials are nonexistent simply because patients do not usually survive more than 6 months.Contrary to the other studies, our PFS [progression-free survival] at 6 months is 35.3 % and overall survival from the treatment start at 1 year is 29.4 % and approximately 11.8 % at 2 years. Even at 15 years, the overall survival is approximately 5.9 %.

This study says:
The data acquired in patients with RGBM [recurrent glioblastoma multiforme] present improved survival outcomes due to ANP therapy, and tolerable toxicity.

This study says:
The best results were observed in children with low-grade glioma, where 74% of patients obtained objective response, and in patients with adenocarcinoma of the colon with liver metastases whose survival rate of more than 5 years is 91% versus 39% in controls on chemotherapy

Case Study
This young man was 10 years old when diagnosed with low-grade astrocytoma in October 1997. Because his tumor grew in a difficult area of involvement, includ-ing the thalamus and brain stem, he was not a candi-date for surgery and did not receive any standard treatment . He began treatment with antineoplastons in April 1998. His contrast-enhancing tumor decreased and finally could no longer be seen on magnetic resonance imaging (MRI) in March 1999. Repeated positron emission tomography (PET) scans did not show tumor recurrence. This patient has made a complete recovery. When he came to us for the first time, he was partially paralyzed and in a wheelchair

This study involving patients with Anaplastic Astrocytoma (AA) a type of brain tumor, says:
A complete response was documented in 7%, partial response in 11%, and stable disease in 22% of patients. Progression-free survival and overall survival at 12 months was 26% and 41% respectively. The only serious toxicity was Grade 3 reversible hypokalemia in 7% of patients. There was no chronic toxicity and there was a high quality of life. ANP shows efficacy with very good toxicity profile in this cohort of patients with recurrent AA.

This study concluded:
The results of this study compared favourably with the responses of patients treated with radiation therapy and chemotherapy. The study continues with accrual of additional patients.

This study says:
CRs [complete response] in the NDIPG [non-diffuse intrinsic pontine glioma] group and very long OS [overall survival] with an excellent quality of life compares favorably to the results of standard treatment. Such cases are incurable and they die, despite the standard treatment, after suffering with a crippling disease. Excellent recovery, normal quality of tumor-free life, and a very long survival of a number of cases gives hope that in some patients, these tumors can be eradicated.

This study says:
The study reached the goal with 4 cases of CR in ITT population. It provides evidence-based research supporting the safety and efficacy of antineoplastons for the treatment of anaplastic astrocytoma which should be confirmed by further studies. More importantly, this treatment was found to be reasonably well tolerated.

This 2015 case study says:
This report discusses a case of a 13-year-old male diagnosed with tectal glioma who obtained a complete response and long-term survival after the treatment with antineoplastons (ANP) in phase II trial…Currently, over 20 years from his diagnosis and over 13 years from treatment start he is symptom-free and leads a normal life.

This study says:
We conclude that in this study antineoplastons have demonstrated a promising level of efficacy against postoperative recurrence with a median CSS [cancer- specific survival] time of 67 months in the AN [Antineoplastons] arm versus 39 months in the control arm, achieved via inhibition of early growth in metastatic tumors from colorectal cancer.

More at Burzynski Research Institute

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Proof that it works
Patient testimonials

Hannah Bradley-Cohen
Hannah Bradley

A woman who was given 18 months to live after being diagnosed with a rare, aggressive brain tumour is now cancer free. Hannah Bradley-Cohen, 30, from North London, was diagnosed with Anaplastic Astrocytoma in early 2011 and given 18 months to live. But she beat the cancer after treatment with a controversial American doctor and went on to marry her partner Pete – a day she thought she’d never live to see. Source: Daily Mail

 

Defying the Odds: Baby Sophia turns 16
Source: localsyr.com
Sophia celebrates her 16th birthday… but doctors once thought she would not live to see her second birthday because of a rare brain tumor called pineoblastoma. Surgery removed the tumor, but it grew back almost overnight.

Following years of treatment by Dr. Stanislaw Burzynski, Sophia is cancer free.
View video


“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Back to top

The Gerson Therapy

 

What the Irish Cancer Society tells us:

The Irish Cancer Society doesn’t even mention this treatment on it’s website.

What the Society doesn’t tell us:

The Gerson Therapy is a natural treatment that activates the body’s extraordinary ability to heal itself through an organic, plant-based diet, raw juices, coffee enemas and natural supplements.

With its whole-body approach to healing, the Gerson Therapy naturally reactivates your body’s magnificent ability to heal itself – with no damaging side effects. This a powerful, natural treatment boosts the body’s own immune system to heal cancer, arthritis, heart disease, allergies, and many other degenerative diseases.
Source: Gerson Website

Proof that it works
It is being used successfully to treat cancer.
There are currently two licensed Gerson clinics where patients are treated, the Gerson Health Centre in Hungary and the Gerson Clinic in Mexico. There are also Certified Gerson Practitioners in Oregan, California and Georgia (USA).

Proof that it works
Published Clinical Trials / Studies / Reviews:

This study concluded:
The 5-year survival rates reported here are considerably higher than those reported elsewhere. Stage IIIA/B males had exceptionally high survival rates compared with those reported by other centers.

This study says:
All 6 cases had a cancer diagnosis with poor prognosis. Despite the presence of some confounding variables, it seems that the Gerson regimen has supported patients to some extent both physically and psychologically.

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Proof that it works
Patient testimonials

Joyce’s Doctor Didn’t Think She’d Be Alive Today
Source: The Gerson Institute

Working for the Gerson Institute, I hear many remarkable stories of people who have used the Therapy to heal themselves. One of these remarkable people is Joyce Forsythe, who just enjoyed another holiday with her family – 7 ½ years after being diagnosed with stage IV mantle cell, non-Hodgkin’s lymphoma. I want to share Joyce’s story with you, because it is not only a remarkable testament to the healing power of the Therapy, it also shows how important it is that people know about the therapy before they become ill.

Since it is her story, I will let Joyce tell you about her healing journey, in her own words.

In July of 2005, at the age of 68, I found a mass in my abdomen. PET and CT scans showed my Joyce Forsythespleen had grown to the size of a football. I had my spleen removed and after a biopsy received a diagnosis of stage IV mantle cell, non-Hodgkin’s lymphoma. My oncologist at Dana Farber recommended a cocktail of four different chemotherapy drugs. He hoped these drugs would put my cancer into remission for a couple of years.

I had learned about Dr. Max Gerson’s therapy 30 years earlier when we lived outside of New York City near his medical practice. As a long-time subscriber to the Gerson newsletter, I had always planned to start the Gerson Therapy if I got cancer. So, I turned down the chemotherapy and told my oncologist that I would do Gerson’s holistic cancer Therapy instead. He reminded me that my cancer was stage IV. Nutrition wouldn’t hurt, but it wouldn’t help. I had read Dr. Gerson’s book and the many patient cases in the newsletters over the years. The oncologist’s warnings were no deterrent for me.

Now retired, my husband Pete and I felt up to the task of rebuilding my body with hourly fresh vegetable juices and doing all that is required by the Therapy. Along with the hard work involved, there was some humor. Pete told me that one time the grocery clerk, ringing up the 20-pound bag of carrots, commented, “I know. You have a horse!”

We were both overjoyed as my lab results began showing the healing taking place. I had not been on the Gerson Therapy long when I took my latest lab reports with me to an appointment with my oncologist. My oncologist took a look at the lab results and exclaimed, “These are absolutely fantastic!” I soon received a letter from him saying “Keep doing what you are doing. The chemo would not have cured your cancer anyway.”

Although the lymphoma specialist at Dana Farber Cancer Institute in Boston was in charge of my case, CT scans, blood tests and cancer marker tests were done at our local cancer center and I met regularly with my local oncologist for interpretation of the results. The local oncologist told me at the end of five years that there was no need for me to keep coming to see her; however she said she didn’t want to lose touch with my case.

She said she thinks of me often as she prescribes for others the drugs that had been recommended for me. She said “Had you taken the recommended chemo, I doubt you’d be alive today.” She asked if I would be willing to send her a copy of the annual lab results ordered by my internist for my future physicals. I told her I’d welcome that. “Seriously,” she said, “we doctors need to know about your success.”

The following week, I went to my internist for my annual physical. After the exam, she commented, “You could be a poster girl for how a woman of 73 should be eating.” In my annual report, she wrote:

“Mrs. Forsythe has cured her own cancer following Gerson Therapy to the ‘T’.”
– Joyce Forsythe, December 2012

More video testimonials at Gerson.org
More written testimonials at Gerson.org

Back to top

Oncolytic Virotherapy

 

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website.

What the Society doesn’t tell us:

About Oncolytic Virotherapy

Source:  Virotherapy.eu
Oncolytic virotherapy is an effective cancer treatment using a special virus, which is capable of finding and destroying malignant tumour cells in the body. There are only three live virus-containing medication in the world and Rigvir is the first registrated and still the one and only genetically unmodified virus available worldwide.


In 2015 RIGVIR was registered in Georgia and included in the Latvian national guidelines for skin cancer and melanoma treatment. According to Dr. Elitn Shapovalora, M.D., “Success rates in early stage melanoma are 90% while in late stage the survival rate is 60%. These rates are significantly higher than the typical survival rate of 9% if treated with conventional therapy.” Melanoma is considered the deadliest type of skin cancer. (Source: EmaxHealth)

Rigvir
Source: International Virotherapy Center
RIGVIR® is the world’s first approved oncolytic virotherapy medicine for the treatment of melanoma, local therapy of skin and subcutaneous metastases of melanoma, prevention of relapse and metastases after surgery.

In clinical practice RIGVIR® is used for the treatment of melanoma, cancers of stomach, colorectum, pancreas, kidney, uterus, bladder, lung, prostate and several types of sarcoma.

RIGVIR® is administered intramuscularly according to personalized treatment protocols. Virotherapy is usually ambulatory and has mild if any side effects. It is important to consult a certified virotherapy specialist to achieve the best possible result.

RIGVIR® was approved in Latvia (an EU member state) in 2004 for cutaneous melanoma therapy.


This Study concluded:

Rigvir significantly prolongs survival in early-stage melanoma patients without any side effect.

 

Proof that it works
It is being used successfully to treat cancer.

The list of clinics and private medical practice institutions accredited by International Virotherapy Center, that have specialized in virotherapy and foreign patient service:

Latvia
Latvian Virotherapy Clinic
Website: www.virotherapycenter.com

Mexico
Hope 4 Cancer Institute – Exclusive partner in Mexico
www.hope4cancer.com

Germany
Medical Center Mommsenstrasse
Website: www.medicalcenter-mommsenstrasse.de/en/

Georgia
MedCenter
Website: www.medcenter.ge

Tbilisi, Georgia
K. Eristavi National Center of Clinical and Experimental Surgery
E-mail: Dr. Nino Gorgadze [email protected], [email protected] ; Dr. Irina Khubua [email protected]

Proof that it works
Published Clinical Trials / Studies / Reviews:

This study says:
In conclusion, Rigvir significantly prolongs survival in early-stage melanoma patients without any side effect.

This study says:
Rigvir significantly improves 3-year and 5-year survival of melanoma and cancer rectum patients.

This 2016 study says:
Using current standard treatments, the survival of patients with the present diagnoses is low. In contrast, the patients described here were diagnosed 3.5, 7.0, and 6.6 years ago, and their condition has improved and been stabile for over 1.5, 6.5, and 4 years, respectively. These observations suggest that virotherapy using Rigvir can successfully be used in long‐term treatment of patients with melanoma stage IV M1c, small cell lung cancer stage IIIA, and histiocytic sarcoma stage IV…

This 2017 study concludes:
The results suggest that Rigvir® in vitro reduces the viability of cells of human melanoma, rhabdomyosarcoma, gastric adenocarcinoma, lung carcinoma, pancreas adenocarcinoma …The present results suggest that the effect of Rigvir® could be tested in other cancers besides melanoma.

This study says:
These observations suggest that virotherapy using Rigvir can successfully be used in long‐term treatment of patients with melanoma stage IV M1c, small cell lung cancer stage IIIA, and histiocytic sarcoma stage IV and therefore could be included in prospective clinical studies.

This 2018 study says:
It has been previously suggested that Rigvir® improves the overall survival in patients with stage IB–IIC melanoma. The present report describes a melanoma unknown primary brain metastasis patient treated with Rigvir® virotherapy. There are limited options to treat brain metastasis because of the brain–blood barrier. The present patient has been stabilized following Rigvir® virotherapy, suggesting that the oncolytic virus Rigvir® might have reached the brain metastasis.

Case report (2018):
In this report, we describe a female patient with unknown primary melanoma brain metastasis treated with the oncolytic ECHO-7 virus Rigvir® after brain surgery. The patient has been stable, as monitored by magnetic resonance imaging, for more than 3.8 years with ongoing therapy. The median expected overall survival from the time of diagnosis is approximately 5 months.

This 2017 study says:
Rv, a wild-type ECHO virus, represents an intriguing possibility among other oncolytic viruses in this context and has been studied mostly in Latvia. Currently, limited retrospective data from Latvia are available. Larger prospective randomized studies and evaluations by investigators outside of Latvia will allow for more rigorous assessments and future development of Rv as a cancer virotherapeutic.

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Proof that it works
Patient testimonials

More at International Virotherapy Center

Back to top

Insulin Potentiation Therapy (IPT)

 

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website.

What the Society doesn’t tell us:

Insulin Potentiation Therapy (IPT)
Insulin Potentiation Chemotherapy (IPT), also known as low dose chemotherapy, is one of the safest and most innovative approaches to treating cancer. It is a kinder, gentler way to fight cancer effectively, including particularly aggressive cancers such as lung cancer and colon cancer, but is also effective on a wide variety of cancer types. IPT is an alternative cancer treatment that has almost none of the side effects such as nausea, radical hair loss, liver damage, and DNA distortion that we see routinely with standard chemotherapy. The key to IPT as a cancer cure is the body’s own hormone – insulin…
Source: EUROMED FOUNDATION

 

Proof that it works
IPT is available in a number of cancer clinics worldwide
, including:
Hyperthermia Centre Hanover (Germany)
Oasis of Hope,
Immunity Therapy Center (US / Mexico)

Proof that it works
Published Clinical Trials / Studies / Reviews

This study says:
We present hereby 3 cases of our original practice, which demonstrate the efficiency of IPT in the treatment of metastatic tumors, following failure of standard chemotherapy…To our opinion the presented cases are indicative of the therapeutic potential of this method with no serious toxicity. We consider that it is possible to apply IPT after unsuccessful standard chemotherapy and radiotherapy.

This study concluded:
Our present experience with IPTLD (in more than 400 treated patients) with various tumors as well as the practical experience of the growing number of doctors practicing the method gives us a reason to assume that IPTLD method provides a real opportunity for resolving one of the most serious problems of toxicity associated with chemotherapy using maximum tolerated doses. A certain advantage of the method along with its effectiveness is the significantly improved quality of life of the treated patients.

This study says:
Overall, both the short and long-term clinical results using insulin in this adjunctive or potentiating role in cancer chemotherapy have been very good, – and better when compared to conventional practice without insulin.

This study says:
A reduction in tumor markers was observed in forty five (53%) of eighty five patients who completed six treatments. Tumor markers in seven (8%) of those eighty five measured within range after six treatments.

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Books

The Kinder, Gentler Cancer Treatment: Insulin Potentiation Targeted LowDose(TM) Therapy
Paperback – October 5, 2009

by Best Answer for Cancer Foundation (Author),

Treating Cancer with Insulin Potentiation Therapy
Paperback – June, 2002
by Ross A. Hauser (Author), Marion A. Hauser (Author)

Proof that it works
Patient testimonials

Lifeworks Wellness Center patients

Dr Donato Perez Garcia patients – written

Dr Donato Perez Garcia patients – video

Annie Brandt (now President of Best Answer for Cancer Foundation )

Back to top

Intravenous vitamin C

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website. Its booklet Cancer and Complementary Therapies says: “There is a lack of strong evidence that vitamin c prevents cancer, with some studies suggesting it may even be harmful”.

What the Society doesn’t tell us:

The Truth About Vitamin C and Cancer

Source: PatrickHolford.com
Vitamin C reduces your risk of cancer, and high doses are an effective anti-cancer therapy. See the latest compelling evidence.

First shown to be a powerful anti-cancer agent in 1971, it wasn’t until 20 years later that vitamin C started to be accepted by the mainstream medical profession. Eating a vitamin C-rich diet substantially reduces the risk of cancer, and high intakes – above 5000mg a day (the equivalent of 100 oranges) – substantially increases the life expectancy of cancer patients.

The overwhelming evidence is that a high intake of vitamin C correlates with a low risk for cancer. In January 1991, Dr Gladys Block, formerly with the National Cancer Institute, published a review [1] of vitamin C research which concluded that there was very strong evidence of a protective effect of vitamin C for non-hormone cancers.

“This is just the sort of thing that public money should be spent on,” says Dr George Lewith, of the University of Southampton, who assesses complementary and alternative medicines for the National Cancer Research Institute.

Proof that it works
It is being used successfully to treat cancer.
Chelation Ireland, the Riordan Clinic (USA), Oasis of Hope Hospital (Mexico) and numerous clinics worldwide offer Vitamin C therapy.

 

Proof that it works
Published Clinical Trials / Studies / Reviews:

This 2017 study says:
In addition, preclinical studies and clinical trials demonstrate the feasibility, selective toxicity, tolerability, and potential efficacy of pharmacological ascorbate in GBM [Glioblastoma] and NSCLC [non-small-cell lung cancer] therapy.

This study says:
AA [Ascorbic Acid] has the potential to selectively kill tumor cells in a manner similar to other tumor cytotoxic chemotherapeutic agents.

This study concluded:
We have presented evidence that vitamin C may be useful in the treatment of cancer. In particular we have produced the following evidence: Vitamin C is toxic to tumor cells. Concentrations of vitamin C that kill tumor cells can be achieved in humans using intravenous vitamin C infusions.

Case study:
Intravenously administered vitamin C as cancer therapy: three cases

This study says:
Our data show that ascorbic acid selectively killed cancer but not normal cells, using concentrations that could only be achieved by i.v. administration and conditions that reflect potential clinical use.

This study says:
There are a wide variety of mechanisms by which ascorbate prevents and inhibits malignant growth… Ascorbate may produce benefits in both prevention and treatment of cancer…The ideal anticancer agent is obviously one that specifically interferes with tumor growth, prolongs survival time, and improves quality of life. There is evi-dence that ascorbate might fit this description…Based on the evidence reviewed herein, we suggest the use of intravenous AA as adjuvant therapy in cancer treatment…

This study says:
From previous studies…we conclude that: concentrations of ascorbic high enough to kill tumor cells can be achieved in humans bu IAA [Intravenous Ascorbic Acid] administration.

This study says:
There are definitely various mechanisms by which Vitamin C attacks malignant growth…The collective evidence supports the notion of increasing ascorbate intake for patients suffering malignancies. Ascorbate may produve benefits in both prevention and treatment of cancer.

This study says:
Evidence suggests that IVC [ Intravenous Vitamin C ] may be able to modulate inflammation, which in turn might improve outcomes for cancer patients. IVC may serve as a safe, adjunctive therapy in clinical cancer care.

This study says:
Twelve years ago, we used infusions of 30 grams of intravenous ascorbic acid, twice per week, and found that metastatic lesions in the lung and liver of a man with a primary renal cell carcinoma disappeared in a matter of weeks…We subsequently reported a case of resolution of bone metastases in a patient with primary breast cancer (1A) using infusions of 100 grams, once or twice per week.

Case study:
Intravenous Vitamin C in a Terminal Cancer Patient.

Case study:
High Dose Intravenous Vitamin C and Long Time Survival of a Patient With Cancer of Head of the Pancreas.

This study says:
In this review we present the fundamental chemistry and biochemistry of ascorbate that may have a role in the mechanisms of high dose, i.v. ascorbate in the treatment of cancer…Epidemiologic evidence suggests that vitamin C-rich foods play a protective role against development of cancer…

This study says:
Although there is still controversy regarding anticancer effects of vitamin C, the use of vitamin C is considered the safe and effective therapy to improve the quality of life in terminal cancer patients.

This study concluded:
Complementary treatment of breast cancer patients with i.v. vitamin C was shown to be a well tolerated optimization of standard tumour-destructive therapies, reducing quality of life-related side-effects.

This study says:
In summary, our analysis of data from cancer patients given IVC, along with our tests of cytokine levels, suggest that IVC may reduce inflammation in cancer patients, and that this reduction in inflammation is correlated with reductions in the tumour markers PSA.

Case Study:
High-Dose Intravenous Vitamin C in the Treatment of a Patient with adenocarcinoma of the kidneys.

Case studies:
High dose intravenous vitamin c and metastatic pancreatic cancer: Two cases

This study says:
In small phase I clinical studies, intravenously administered ascorbate was safe. Survival was doubled in patients with metastatic pancreatic cancer…

This study says:
The prognosis for patients diagnosed with pancreatic cancer remains dismal, with less than 3% survival at 5 years. Recent studies have demonstrated that high-dose, intravenous pharmacological ascorbate (ascorbic acid, vitamin C) induces cytotoxicity and oxidative stress selectively in pancreatic cancer cells vs. normal cells, suggesting a promising new role of ascorbate as a therapeutic agent.

This study says:
Here, we report the use of PAA [Pancreatic ductal adenocarcinoma ] in a patient with poorly differentiated stage IV PDA as an exclusive chemotherapeutic regimen. The patient survived nearly 4 years after diagnosis, with PAA as his sole treatment, and he achieved objective regression of his disease.

This study says:
As the progression of disease continued after chemotherapy, the child, at the age of 2.8 years, was started on high-dose intravenous vitamin C (IVC) treatment (7-15 grams per week) for 30 months. After 30 months, the results of IVC treatments demonstrated reduction and stabilization of the tumors in the optic chiasm, hypothalamus, and left optic nerve according to radiographic imaging. The right-sided optic nerve mass seen before IVC treatment disappeared by the end of the treatment. CONCLUSIONS This case highlights the positive effects of treating NF1 glioma with IVC. Additional studies are necessary to evaluate the role of high-dose IVC in glioma treatment.

Case study:
We report a case of regression of multiple pulmonary metastases, which originated from hepatocellular carcinoma after treatment with intravenous administration of high-dose vitamin C.

This study says:
We are able to show that average z-scores for several inflammatory and angiogenesis promoting cytokines are positive, indicating that they are higher than averages for healthy controls, and that their levels decreased over the course of treatment.

This study says:
Comparison of control and study groups revealed that i.v. vitamin C administration resulted in a significant reduction of complaints induced by the disease and chemo-/radiotherapy, in particular of nausea, loss of appetite, fatigue, depression, sleep disorders, dizziness and haemorrhagic diathesis.

This study concluded:
Compared with chemotherapy, IVC therapy, in combination with a diet and supplement regimen, is tolerated well, appears to have antitumor activity in some cases, has been administered alongside conventional therapy without impairing response, is safe for most patients, and is inexpensive. It also appears to increase the quality of life for patients. IVC therapy has the potential to become an important chemotherapeutic method to combat cancer.

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Proof that it works
Patient testimonials

Back to top

Laetrile (Amygdalin)

 

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website.

What the Society doesn’t tell us:

Laetrile is a patented synthetic drug made from the natural compound amygdalin, found in the seeds of many fruits, such as apricot, almond, plum, peach pits, and apple seeds, .
Laetrile is also known as Amigdalin or vitamin B17.


Oasis of Hope Hospital uses Amygdalin.
“Oasis of Hope uses amygdalin (Laetrile) to attack the tumor. The cyanide released by amygdalin is one of the best killers of malignant cells as well. Amygdalin has a double punch. It lowers cancers resistance to treatment and it releases cyanide to kill cancer cells directly.

Doctors at Oasis of Hope have experienced positive results with amygdalin. These results encourage us to continue offering laetrile to our patients. Laterile should be looked at as a therapy that can be combined with additional alternative cancer treatments and/or other anti-tumor agents. This is the appropriate future of amygdalin.”
Source: Oasis of Hope

Proof that it works
It is being used successfully to treat cancer.

Laetrile Infusion therapy is available at Hyperthermia-Centre-Hannover
and Oasis of Hope Hospital and a number of other cancer clinics worldwide.

Proof that it works
Published Clinical Trials / Studies / Reviews:

This study says:
Therefore the anti-tumor effect of amygdalin is one of the hots topic in recent years. It has anticancer function by decomposing carcinogenic substances in the body, killing cancer cells, blocking nutrient source of tumor cells, inhibiting cancer cell growth, and could also reduce the incidence of prostate cancer, lung cancer, colon cancer and rectal cancer. It has been manufactured and used to treat cancer in America, Germany, Italy, Japan, Philippines and other 20 countries. It can also ameliorate the symptoms of patients in advanced stage of cancer, and prolong their survival period.

This study says:
Here, we have shown that amygdalin induces apoptotic cell death in human DU145 and LNCaP prostate cancer cells by caspase-3 activation through down-regulation of Bcl-2 and up-regulation of Bax. The present study reveals that amygdalin may offer a valuable option for the treatment of prostate cancers.

This study says:
Amygdalin has also been shown to inhibit the adhesion of breast cancer cells, lung cancer cells and bladder cancer cells by decreased expression of integrin’s, reduction of catenin levels and inhibition of the Akt-mTOR pathway, which may consequently lead to inhibition of metastases of cancer cells. It has also been revealed that amygdalin in renal cancer cells increased expression of p19 protein resulting in inhibition of cell transfer from G1-phase to S-phase, and thus inhibited cell proliferation.

This study says:
So, amygdalin enhances deceleration of cell cycle by blocking cell proliferation and growth. The current review highlights that amygdalin has potential to be used as an anticancer agent in cancer therapy.

This study concludes:
These results suggest that amygdalin have an anticancer effect via downregulation of cell cycle-related genes in SNU-C4 human colon cancer cells, and might be used for therapeutic anticancer drug.

This study says:
In this study, we found that the viability of human cervical cancer HeLa cell line was significantly inhibited by amygdalin…The results in the present study suggest that amygdalin may offer a new therapeutic option for patients with cervical cancer.

This 2015 study says:
These results strongly suggested that amygdalin was likely to have anti-metastatic NSCLC effect. This study offers information of the role of amygdalin that may be useful as a therapeutic target in lung tumors.

This 2015 study says:
In conclusion, exposing RCC [ Renal Cell Carcinoma ] cells to amygdalin inhibits metastatic spread and is associated with downregulation of α5 and α6 integrins. Therefore, amygdalin exerts antitumor activity in vitro in RCC.

This study says:
Amygdalin dose-dependently reduced growth and proliferation in all three bladder cancer cell lines, reflected in a significant delay in cell cycle progression and G0/G1 arrest. Amygdalin, therefore, may block tumor growth by down-modulating cdk2 and cyclin A.

This 2016 study says:
Amygdalin exhibits significant antitumor activity in both castration-sensitive and castration-resistant PCa cell lines and merits further evaluation for therapeutic purposes.

This study says:
In vivo, amygdalin administration inhibited the growth of HeLa cell xenografts through a mechanism of apoptosis. The results in the present study suggest that amygdalin may offer a new therapeutic option for patients with cervical cancer.

This study says:
Taken together, this study demonstrates that amygdalin induces apoptosis and inhibits adhesion of breast cancer cells. The results suggest a potential application of amygdalin as a chemopreventive agent to prevent or alleviate progression of breast cancer, especially TNBC [Triple Negative Breast Cancer ].

The National Cancer Institute Laetrile/Amygdalin (PDQ®)–Patient Version includes the following summary:

  • A laboratory study of amygdalin reported that it somewhat slowed the growth of colon cancer cells.
  • A laboratory study of amygdalin reported the higher the dose of amygdalin, the more likely the prostate cancer cells were to respond.
  • A laboratory study of amygdalin given with beta-D-glucosidase reported a time and dose-dependent response in hepatoma cells. The longer amount of time that amygdalin and beta-D-glucoside were given and the higher the dose, the more likely the hepatoma cells were to respond.
  • A laboratory study of amygdalin reported the higher the dose of amygdalin, the more likely the cervical cancer cells were to respond…

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Book World Without CancerWorld without Cancer: The Story of Vitamin B17
by G. Edward Griffin
This is the most complete and authoritative treatise ever produced on Laetrile. It explains the theory by which Laetrile is believed to work. Case histories are included.

 

 

Laetrile Case Histories; The Richardson Cancer Clinic Experience
by John A. RichardsonBook Laetrile Case Histories

Here are 62 case histories proving beyond any doubt that Laetrile (Vitamin B17) works in the control of cancer. These are not anecdotal stories or cases of people who never had cancer in the first place. Each history is authenticated by a firm diagnosis and meticulous medical documentation.

Proof that it works
Patient testimonials

 

Back to top

Issels® Immunotherapy

 

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website.

What the Society doesn’t tell us:

From the Issels website:
“The Issels Integrative Oncology has two lines of approach, which are of equal importance and complement each other:

  1. Non-toxic therapies specifically directed against the cancer cells and tumors, such as cancer vaccines and cell therapies; personalized standard cancer treatment protocols if needed.
  2. Non-toxic immunobiologic core therapy to alter the tumor microenvironment with its essential role in cancer progression or regression and healing.

Issels® Immunotherapy is highly individualized, specific and non-toxic. It uses cancer vaccine and cell therapies that are cultured from the patient’s own immune cells, in the presence of the patient’s own tumor antigens.

Issels® Immunotherapy does not have any adverse side effects, in contrast to the novel, pharmaceutically produced drugs called immunotherapy as they affect the immune system. These drugs have shown to cause serious, often life-threatening reactions in a variety of patients.

Issels® Immunotherapy for Cancer is a very comprehensive treatment program that is not limited to one single modality such as a vaccine, a drug or another monotherapy. It integrates treatment components that enhance one another in fighting the cancer.

Issels ® Immunotherapy focuses with the same importance on destroying cancer cells and tumors, as well as on altering the body’s internal environment that has been promoting the cancer growth. It is applicable to all cancer types and stages either on its own or in combination with advanced US FDA approved gene-targeted cancer therapies and standard treatments.

Issels® Immunotherapy for Cancer is not a trial. It has a track record of many years of long-term tumor remissions and is administered by doctors with extensive experience in Immuno-Oncology.” Source: Issels.com

It is being used successfully to treat cancer.
Issels therapy is available at Issels Clinic

Published Clinical Trials / Studies / Reviews

This study concluded:
The Issels Treatment protocol has shown statistically significant overall improvement in NKC levels following three weeks of intensive treatment which supports the premise that the anti tumor immunotherapy approach is beneficial to overall survival and quality of life.

Case study
The clinical findings of this case report suggest that metastatic melanoma is responsive to the Issels Immunotherapy protocol as evidenced by radiographic and laboratory criteria.
In addition, as a reasonable and feasible alternative/complement to current standard treatment regimens, the Issels protocol also appears to be safe and well-tolerated.

This study says:
These results indicate the possibility, by using the combined general and immunotherapy technique, of producing prolonged remission in a significantly larger number of patients with progressive malignant disease than has so far been the general experience. Most of the survivors are alive and well 15 or more years after therapy.

Patient testimonials

More Video testimonials

Lots of Written Testimonials

Back to top

The Budwig Protocol / Diet

 

What the Irish Cancer Society tells us:

There is no information about this treatment on the Irish Cancer Society website

What the Society doesn’t tell us:

The Budwig Protocol has it its heart a diet with its roots in a phenomenon known as the “Warburg Effect” discovered by 1931 Nobel Prize winner, medical doctor and biochemist, Otto Heinrich Warburg. Through his work on respiration he discovered that, in the absence of oxygen, cancer cells would metabolise sugar which enabled them to multiply. In the same era, Dr Johanna Budwig, another eminent German biochemist, found that highly unsaturated cold-pressed linseed oil would carry oxygen into the cells to fight cancer. Increasingly modern scientific research supports the benefits to health of the diet.
Source: www.budwig-diet.co.uk/

Proof that it works
It is being used successfully to treat cancer.

The BUDWIG CENTER is an officially approved Cancer Clinic.
The Budwig Protocol is also used in 3E Center, Arcadia Praxis Klinik and other cancer clinics.

A well-respected scientist, Dr Budwig conducted much research to test her theories. However no clinical trials of the Budwig diet exist at this time.
Note: Clinical trials cost hundreds of millions of dollars. If a treatment is not patentable by a pharmaceutical company it is unlikely to be tested in a clinical trial.

Proof that it works
Patient testimonials

Budwig Protocol Led to Dramatic Comeback for Mesothelioma Survivor
Source: Asbestos.com

When they left the hospital in June, Marilyn B. was told that her husband, James, belonged in a hospice facility, where they could make him as comfortable as possible through his final weeks with malignant pleural mesothelioma.

Tim-Blog-James-BroomerFortunately, she didn’t listen, taking a detour to their home instead, arriving with her own shot-in-the-dark plan, unwilling to accept the medical advice that previously led to the chemotherapy regimen that almost killed him.

Thank goodness, she didn’t listen this time. She just started feeding him.

The couple, whose last name is being withheld over privacy concerns, turned to the Budwig Protocol, a radical change of diet that revolves around a special oil-protein mixture that includes cold-pressed flaxseed oil and cottage cheese. It provides the essential omega-3 acids that become the sparks for cells to detoxify, fill with oxygen, and function optimally.

It has worked miraculously for James.

“When we left the hospital, all they talked about was palliative care, that he needed to be where they can take care of you when you’re dying,” Marilyn said from their home in Ottawa, Ontario. “I said no, no, no. There has to be something else out there. We just weren’t ready to give up. I don’t know exactly why this works, or how long it will work, but it’s remarkable how well he is right now. He went out and shoveled some snow off the drive the other day.” Read the full story at Asbestos.com

BREAST CANCER
Source: Budwig Center
From: KATHIE FITZPATRICK

[email protected]
Sent: Tuesday June 9, 2015 6:50

To: [email protected]
CC: KATHIE FITZPATRICK
Subject: Dramatic results from Budwig
FOCC dissolving stage three breast cancer

Hello Budwig Staff:
I have a dramatic testimony that is medically documented as I have been seeing an oncologist at Northstar Cancer treatment center in Yakima Wa. USA since Sept. of 2014 until now. My stage three breast cancer that involved a high grade large tumor about 9 cm in the right breast is now all but dissolved and almost gone. I have dramatic before and after MRI reports. I can’t say that prayer by many people was not a big part of it, it was! But I was directed to use the Budwig protocol when I had never heard of it before. It brought amazing results.

Exciting. I went to having a 90 percent high grade cancer which was filling up 1/2 to 3/4 of the kathie-fitzpatrickright breast in my first MRI in Sept. 2014 to having dramatic improvement in my latest MRI here the end of May. The surgeon told me that I was to have surgery then (Sept. 2014) it would need to be a mastectomy. The same surgeon, Dr. Bernfield was amazed at the new report. I only went back to him as a referral from my oncologist, Dr. Vicky Jones, as a comparison, and what would surgery look like today if I had any. However it looks like it is dismantling and going away!

Doctors these days do not know what to do when somebody’s cancer appears to be going away. He said he needed to talk to the radiologist. “IS HE SAYING IN THE REPORT IT IS GREATLY IMPROVING…IS HE SAYING IT’S NOT THERE? I’LL CALL YOU.” Then he promptly went on vacation for a week, so I have not heard back from him. When we parted he said that he hoped that it would keep shrinking.

HERE ARE SOME QUOTES FROM MY MRI REPORT:

Right breast: The areas of marked signal alteration in the right breast that were present previously on 09/08/2014 are markedly less “”prominent on today’s study. There is no obvious skin thickening identified. We note that there is no evidence for any enhancing lesion in the retroareolar glandular pattern or the more posterior glandular pattern. Both of which have diminished significantly in signal size and content. There are no areas of abnormal enhancement in the right breast.

“I originally had a tiny lump, about 1/4 the size of a pea (5mm) which was spotted in an area of calcification. The large 9 cm one was not picked up on the mammogram at all, and had to be evaluated through ultra sound and MRI. So apparently both have diminished.

I also use mushroom complexes such as AHCC and Turkey Tail extract, and modified Pectin-C such as Pecstisol (eco Nugenics), but the Budwig Protocol has been the main core treatment. I take the mixture, 4 TBS flax seed oil to 1/2 cup of lowfat cottage cheese, I envelope Stevia, a few strawberries fresh or frozen. I often double or triple the recipe, blend well in the electric blender. Serve with blueberries or a little more fruit of choice. Wild blue berries are the most anti-oxidant, and can be obtained frozen through various venders. I drink green tea in the morning, plus a green tea supplement Tegreen, equivalent to 7 cups of green tea in one capsule (Nuskin)

I have not completely eliminated meat, but eat less meat and more steamed or raw vegetables and do juicing and vegetable drinks in the Nutri-Bullet. The meats are Buffalo, steaks or burger (no hormones) wild salmon, organic chicken or grass fed beef, no hormones. The meat is a small helping more green salads and veggies.”

PROSTATE CANCER

Håkon Volden
45 Year old Man from Norway

Hakon-VoldenHakon came to the BUDWIG CENTER for the full 2 week Gold Program in Jan 15, 2015. After following the Budwig program carefully the doctors declared his cancer had gone into remission in March 2015. Hakon came back to the BUDWIG CENTER in May 2015 for additional VEGA tests and maintenance treatments. No cancer was found in the tests.

 

BRAIN TUMOR

From: [email protected]
Sent: Wednesday Feb 18, 2015 5:18
To: Lloyd Jenkins
Subject: Re: Testimonial from Yekaterina (Katya) Grishchenko

My brain tumor was discovered when I was 11 years old (14 years ago this December). It was Yekaterina-Grishchenkodiscovered, because all of the sudden, I developed Bells Palsy (paralysis of the face). A scan showed that the tumor was blocking the brain fluid from draining so it kept building up and eventually caused too much pressure on my brain. I had no problems with it otherwise.

After the tumor bled out on June 30, 2010, I had brain surgery. On October 1, 2010, 90% of the tumor was removed. They could not remove all 100% because the doctor did not know where the tumor ended and my brain began. They recommended that I have Chemotherapy and radiation, but we chose not to go that route.

After being treated at the BUDWIG CENTER, the biopsy showed that the tumor was not cancerous, but it has been about eight months since my last treatment at the Budwig Center. My cancer has totally gone into remission and I want to tell the world about this good news

Yekaterina Grishchenko

“When they decide they can’t do anything for you anymore, that’s when you feel lost. And we were there. We were fortunate to find something that worked for us. Otherwise, I don’t know what would have happened.”
Marilyn B., whose husband was given only weeks to live with mesothelioma but who recovered using the Budwig Diet.

Lots more testimonials at Budwig Center

More testimonials at Healing Cancer Naturally

“Alternative therapies are not scientifically proven.”
Irish Cancer Society

Back to top

Please share this page